A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the pharmacokinetics (PK) of necitumumab in
combination with gemcitabine-cisplatin in participants with advanced malignant solid tumors
and to assess the potential for drug-drug interactions between necitumumab and
gemcitabine-cisplatin.